Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Quercus stellata pollen is an allergenic extract derived from the pollen of the Post Oak tree (*Quercus stellata*). It is primarily utilized as a diagnostic tool in clinical allergy testing, such as skin prick tests or intradermal tests, to identify individuals with hypersensitivity to Post Oak allergens. As a biological extract, it contains a complex mixture of proteins and other molecules that trigger an IgE-mediated allergic response in sensitized patients. It may also be used in allergen immunotherapy (desensitization) to treat allergic rhinitis or asthma triggered by this specific pollen. The extract works by cross-linking specific IgE antibodies on the surface of mast cells and basophils, leading to the release of inflammatory mediators like histamine.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on quercus stellata pollen.